FIELD: medicine, pharmacy, biochemistry. SUBSTANCE: invention proposes a novel active component of pharmaceutical composition, food composition or beverage for prophylaxis or treatment of lipodystrophy or cirrhosis of liver in mammals, among them, in humans. The known flavonoids hesperidin or hesperetin are used as this component. EFFECT: expanded assortment of agents of designation claimed. 9 cl, 2 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NARINGIN AND NARINGENIN AS AGENTS FOR PROPHYLAXIS OR TREATMENT OF LIVER DISEASE | 1998 |
|
RU2201228C2 |
| HESPERIDIN AND HESPERETIN AS INHIBITORS OF 3-HYDROXY-3-METHYL-GLUTARYL-COA-REDUCTASE | 1997 |
|
RU2174392C2 |
| NARINGIN AND NARINGENIN AS INHIBITOR OF ACTIVITY OF 3-HYDROXY-3-METHYLGLUTARYL-COA-REDUCTASE | 1997 |
|
RU2174393C2 |
| CITRUS FRUIT PEEL EXTRACT AS INHIBITOR OF 3-HYDROXY-3-METHYL-GLUTARYL-COA-REDUCTASE | 1997 |
|
RU2173164C2 |
| BIOFLAVONOIDS AS BLOOD GLUCOSE LEVEL- DECREASING AGENT | 1998 |
|
RU2203050C2 |
| INSECTICIDE COMPOSITIONS CONTAINING COMPOUNDS WITH INHIBITOR ACTIVITY AGAINST ACYL-CoA:CHOLESTEROL ACYLTRANSFERASE OR SALTS THEREOF AS ACTIVE INGREDIENTS | 2003 |
|
RU2305403C2 |
| COMPOSITION CONTAINING MONEYWORT EXTRACT FOR PREVENTING AND TREATING METABOLIC DISORDERS | 2008 |
|
RU2481851C2 |
| MACROPOROUS CHITOSAN GRANULES AND METHOD FOR THEIR PREPARING, METHOD FOR CULTURING CELLS | 2000 |
|
RU2234514C2 |
| ANTIVIRAL FLAVONOID COMPOUND | 2006 |
|
RU2398595C2 |
| METHOD OF INHIBITING SUCTION AND/OR INCREASING LIPID RELEASE WITH USING D-PSICOSE | 2016 |
|
RU2725145C2 |
